19 June 2013
Keywords: Fosun Pharma, Aleph Biomed, M&A, Flue vaccine
Article | 15 February 2011
With the aim of expanding its production portfolio and competitive position, Chinese drugmaker Fosun Pharmaceutical has bought a 75% stake in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 February 2011
16 February 2011
14 February 2011
© 2013 thepharmaletter.com